Using human genetics to understand the disease impacts of testosterone in men and women
Top Cited Papers
- 10 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (2), 252-258
- https://doi.org/10.1038/s41591-020-0751-5
Abstract
Testosterone supplementation is commonly used for its effects on sexual function, bone health and body composition, yet its effects on disease outcomes are unknown. To better understand this, we identified genetic determinants of testosterone levels and related sex hormone traits in 425,097 UK Biobank study participants. Using 2,571 genome-wide significant associations, we demonstrate that the genetic determinants of testosterone levels are substantially different between sexes and that genetically higher testosterone is harmful for metabolic diseases in women but beneficial in men. For example, a genetically determined 1 s.d. higher testosterone increases the risks of type 2 diabetes (odds ratio (OR) = 1.37 (95% confidence interval (95% CI): 1.22–1.53)) and polycystic ovary syndrome (OR = 1.51 (95% CI: 1.33–1.72)) in women, but reduces type 2 diabetes risk in men (OR = 0.86 (95% CI: 0.76–0.98)). We also show adverse effects of higher testosterone on breast and endometrial cancers in women and prostate cancer in men. Our findings provide insights into the disease impacts of testosterone and highlight the importance of sex-specific genetic analyses.Keywords
This publication has 43 references indexed in Scilit:
- A Genome-Wide Association Meta-Analysis of Circulating Sex Hormone–Binding Globulin Reveals Multiple Loci Implicated in Sex Steroid Hormone RegulationPLoS Genetics, 2012
- Genetic Determinants of Serum Testosterone Concentrations in MenPLoS Genetics, 2011
- GCTA: A Tool for Genome-wide Complex Trait AnalysisAmerican Journal of Human Genetics, 2011
- Commentary: Testosterone and the metabolic syndrome: cause or consequence?International Journal of Epidemiology, 2010
- Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studiesInternational Journal of Epidemiology, 2010
- Fkbp52 Regulates Androgen Receptor Transactivation Activity and Male Urethra MorphogenesisOnline Journal of Public Health Informatics, 2010
- Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetesHuman Molecular Genetics, 2009
- Sex Hormone–Binding Globulin and Risk of Type 2 Diabetes in Women and MenThe New England Journal of Medicine, 2009
- Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective StudiesJNCI Journal of the National Cancer Institute, 2008
- Sex Differences of Endogenous Sex Hormones and Risk of Type 2 DiabetesJAMA, 2006